LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
February 26, 2024 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
Agreement Focuses on Combining LIXTE’s LB-100 with Various Innovative Cancer Immunotherapies PASADENA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and...
First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial
January 29, 2024 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, Jan. 29, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), today announced the dosing of the first patient in a Phase...
World’s Largest Volleyball Event set to host 56,000 participants in Orlando, June 17-29
June 17, 2021 15:02 ET
|
Amateur Athletic Union
Orlando, Fla., June 17, 2021 (GLOBE NEWSWIRE) -- The Amateur Athletic Union (AAU) is ready to host the world’s largest AAU Volleyball tournament on June 17-29, the 48th AAU Junior National...
Advanced Biomedical Technologies Inc. Launches Sales Campaign
November 06, 2019 09:00 ET
|
Advanced Biomedical Technologies Inc
SHENZHEN, CHINA and NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a pioneer developer and manufacturer of novel orthopaedic internal fixation...